World-Leading Regulatory Affairs Expert Joins Inceptua Group
World-Leading Regulatory Affairs Expert Joins Inceptua Group Luxembourg,...
Read More
Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treatment of ovarian cancer
European Commission and MHRA approves transfer of marketing...
Read More
Scott Forde joins Inceptua as Senior Director, Business Development.
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua strengthens early access division with key business development hire
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua Partners with Global Blood Therapeutics for an Early Access Program for Voxelotor for Patients with Sickle Cell Disease
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua receives approval of marketing authorization transfer of Jetrea® (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua Group Announces Partnership with BioCryst on Expanded Access Program for Patients with Hereditary Angioedema
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Global License Agreement a Building Block in Strategic Growth Plans
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Oxurion and Inceptua Group enter global license agreement for the commercialization of JETREA®
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua and Portola enter exclusive distribution agreement for Ondexxya®
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Head of Global Patient Access joins Inceptua
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More